Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01202448
NCT01202448
Completed
Not Applicable

Prospective Cohort Study With Risk-adapted Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma

Samsung Medical Center2 sites in 1 country600 target enrollmentAugust 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiffuse Large B-cell Lymphoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diffuse Large B-cell Lymphoma
Sponsor
Samsung Medical Center
Enrollment
600
Locations
2
Primary Endpoint
CNS relapse/involvement
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study is to evaluate the incidence of central nervous system (CNS) relapse or metastasis in patients with diffuse large B-cell lymphoma.

Detailed Description

We dichotomize patients according to the risk of CNS involvement. Then, we perform CNS evaluation in patients at risk of CNS involvement. We prospectively monitor whether CNS relapse or metastasis occurs in patients with diffuse large B-cell lymphoma

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
February 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kim, Seok Jin

Associate professor

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • •Newly diagnosed patients with diffuse large B cell lymphoma
  • •\> 20 years
  • •life expectancy more than 6 months
  • •Written informed consent

Exclusion Criteria

  • •Refusal to informed consent
  • •Lymphomas other than diffuse large B cell lymphoma
  • •Primary CNS lymphoma

Outcomes

Primary Outcomes

CNS relapse/involvement

Time Frame: Up to 2 years after participants are enrolled.

After enrollment, patients will be monitored to check the CNS relapse or involvement

Secondary Outcomes

  • survival(Up to 2 years after participants are enrolled)

Study Sites (2)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Neurologic Evaluation of Patients After Transapical Beating-Heart Septal MyectomyHypertrophic Obstructive Cardiomyopathy \(HOCM\)Neurologic EvaluationMagnetic Resonance Imaging \(MRI\)Transapical Beating-Heart Septal MyectomyCardiac Surgery Involving Left Heart Operation
NCT06078410Xiang Wei50
Recruiting
Not Applicable
Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating DiseasesMultiple Sclerosis, MSNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseAcute Disseminated EncephalomyelitisClinically Isolated SyndromeDemyelinating Disorder
NCT06541626Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University450
Recruiting
Not Applicable
Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous MalformationsHemangioma, Cavernous, Central Nervous System
NCT06214767Beijing Tiantan Hospital1,200
Active, not recruiting
Phase 1
Clinical study trying to answer the question if preventive treatment (prophylaxis) will lower the number of relapses (returns of the disease) in central nervous system in one of the aggressive form of lymph node cancer. The study is being performed in several centres, data will be collective prospectively and patients will be distributed to treatment groups by chance.Diffuse large B-cell lymphomaMedDRA version: 21.0Level: PTClassification code 10012818Term: Diffuse large B-cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2015-000591-97-CZKooperativní lymfomová skupina, o.s.200
Recruiting
Not Applicable
Clinical Prognostic Score to Predict Relapse in VLVisceral Leishmaniasis
NCT05602610Institute of Tropical Medicine, Belgium741